Friberg Gregory R 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Oct 1, 2024
Insider Transaction Report
Form 4
Friberg Gregory R
EVP, Chief R&D Officer
Transactions
- Award
Stock Option (Right to Buy Common Stock)
2024-09-30+49,850→ 49,850 totalExercise: $70.29From: 2025-09-30Exp: 2034-09-29→ Common Stock (49,850 underlying) - Award
Common Stock
2024-09-30+21,190→ 21,190 total - Award
Common Stock
2024-09-30+7,870→ 29,060 total
Footnotes (2)
- [F1]Restricted stock units granted on September 30, 2024. Price not applicable.
- [F2]Option grant vests 12/48th on September 30, 2025 and 1/48th per month thereafter.